Chemical Compound Background 9 masthead

Director/PDMR Dealing

Posted date: February 24, 2021

Download Full Message Here

24 February 2021

Iofina plc

(“Iofina” or the “Company“)

Director/PDMR Dealing

Iofina plc (AIM: IOF) announces that it received notification on 23 February 2021 that Thomas M Becker, Chief Executive Officer and President of the Company, purchased a total of 30,680 ordinary shares in the capital of the Company at an aggregated price of 11.90 pence per share. Further details are set out in the Notification of Dealing Form below.

Following the purchase, Dr. Becker holds 124,430 shares, representing approximately 0.065 per cent. of the Company’s share capital. The shares purchased represent 0.016 per cent. of the Company’s issued share capital.

Director/PDMR Ordinary shares purchased Resultant interest in ordinary shares Resultant percentage of issued ordinary shares
Non-Executive Chairman 30,680 124,430 0.065%

 This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Enquiries:

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +1 859 356 8000

Christopher Raggett/Giles Rolls/Matthew Radley

Tim Redfern (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

Media Contact:

Charles Goodwin/Joe Burgess

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the persons discharging managerial responsibilities / person closely associated

 

a) Name Thomas M Becker
2

Reason for the notification

 

a) Position/Status PDMR – Chief Executive Officer and President
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Iofina plc
b) LEI 213800QDMFYVRJYYTQ84
4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial

instrument, type of

instrument

Identification code

Ordinary shares of £0.01 each

GB00B2QL5C79

b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s)
Price(s) (p) Volume(s)
11.75p 100
11.75p 580
11.90p 30,000
d)

Aggregated information

–       Aggregated volume

–       Price

30,680

11.9p

e) Date of transaction 22 February 2021 and 23 February 2021
f) Place of transaction London Stock Exchange, AIM Market (XLON)
Previous ArticleDirector/PDMR Dealing Next ArticleDirector/PDMR Dealing
Translate »